Introduction {#s1}
============

Duration of cardiac repolarization has been previously studied by genome-wide association studies (GWAS) and led to the discovery of 35 associated loci ([@ddw058C1]). However, abnormalities of repolarization are not limited to changes in duration, but are also captured by changes in amplitudes ([@ddw058C2]). Ventricular repolarization occurs in a geometric pattern across the heart. This process entails differences in timings of recovery across the ventricular wall and between regions of the left ventricle after ventricular depolarization. The cellular basis for the origins of the ST-segment and adjacent T wave (ST-T wave) amplitudes is still under debate, but is generally thought to arise as a consequence of electrical heterogeneities that exist within the ventricular myocardium ([@ddw058C3]). It is thought that the ST-T wave begins when the epicardial cells start to recover ahead of the midwall and endocardial cells. Electrical currents flow from the midmyocardial and endocardial regions toward the epicardium, resulting in a gradual rise in current, until the epicardium is fully repolarized and the currents have reached maximal intensity (T-top) ([@ddw058C4]). Continuous indices of T-wave amplitudes are not only relevant in patients with myocardial infarction ([@ddw058C5]), ischemic cardiomyopathy ([@ddw058C6]) and a malignant form of ER ([@ddw058C7]), but also in non-diseased population cohorts. In the general or healthy population, inversions of the ST-T wave are strongly associated with adverse outcome ([@ddw058C8]--[@ddw058C10]), but also minor depressions or elevations in ST-T-wave amplitudes are predictors of cardiovascular mortality ([@ddw058C11]--[@ddw058C13]) and disease ([@ddw058C10],[@ddw058C14]).

Deviations of ST-T-wave amplitudes can be indicative of a variety of cardiac pathologies, including myocardial ischemia, ventricular hypertrophy, long-QT syndrome, ER and Brugada syndrome ([@ddw058C2],[@ddw058C8],[@ddw058C12],[@ddw058C15]--[@ddw058C17]). For clinical use, phenotypes are dichotomized based on optimal sensitivity and specificity to predict worse outcome. However, there is no evidence that the underlying biology of ST-T wave is truly binary. Therefore, we hypothesized that common genetic variation involved in the biology of quantitative ST-T waves traits might provide additional biological insights into the (patho)physiological mechanisms of repolarization. GWAS have proven to be a powerful and unbiased tool to identify novel mechanisms and pathways.

Here, we aim to identify key genetic loci associated with the heart\'s repolarization phase during the ST-T wave of the electrocardiogram (ECG) to further advance our knowledge on biological factors regulating cardiac repolarization and thereby provide new gene targets for future study.

Results {#s2}
=======

Genome-wide discovery analysis and replication {#s2a}
----------------------------------------------

We performed genome-wide meta-analyses in 15 943 subjects of European descent on the ST-T wave ([Supplementary Material, Table S1](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)), with up to 2 316 136 directly genotyped and imputed autosomal single nucleotide polymorphisms (SNPs). Phenotypes for the ST-segment amplitudes and T-wave amplitudes were derived from leads used in the clinic for diagnosing Brugada syndrome ([@ddw058C17]) (Septal, V~1~ and V~2~) and early repolarization (ER) ([@ddw058C16]--[@ddw058C18]) (lateral: I, aVL, V~5~, V~6~ and inferior: II, III, aVF). Aiming to capture additional information available on the ECG during cardiac repolarization, we also investigated the other lead recordings (Anterior: V~3~, V~4~ and lead aVR) that are presumed to have anatomical meaning ([Supplementary Material, Table S2](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). This resulted in 10 phenotypes representing the ST-T-wave amplitude: 5 ST-segment amplitudes and 5 T-wave amplitudes (Fig. [1](#ddw058F1){ref-type="fig"}A). We estimated that studying 10 correlated ST-T wave phenotypes was equal to studying eight independent phenotypes (see the 'Materials and Methods' section); therefore, the threshold of genome-wide significance was set to *P*\< 5 × 10^−8^/8 (*P* \< 6.25 × 10^−9^). We considered a threshold of *P* \< 1 × 10^−6^ to be suggestive of association and used this threshold to prioritize SNPs for replication. The genome-wide meta-analysis across the 10 ST-T-wave phenotypes identified a total of 36 loci to pass the suggestive threshold for association with at least one of the ST-T wave phenotypes. There was no evidence for inflation of test statistics in the final meta-analysis ([Supplementary Material, Table S3](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)) or significant heterogeneity. Of the 36 loci, there were multiple loci were associated with one or more 10 ST-T-wave phenotypes: totaling 95 genotype--phenotype associations (*P* \< 1 × 10^−6^, [Supplementary Material, Table S4](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). Figure 1.(**A**) We conducted genome-wide analyses of ST-segment amplitudes at 80 ms after J-point and T-wave (top) amplitudes reflecting temporal patterns in the cardiac cycle during the repolarization phase. In total, 12 phenotypes were defined by taking the sum of the ST-T-wave amplitudes in the lateral (I, aVL, V~5~ and V~6~), inferior (II, III and aVF), septal (V~1~ and V~2~), anterior (V~3~ and V~4~) leads and lead aVR. These lead groups cover the combination of leads with presumed anatomical meaning of the heart, and those that are used in the clinic for diagnosing Brugada syndrome ([@ddw058C17]) and ER ([@ddw058C16]--[@ddw058C18]). (**B**) Genome-wide association analyses of all ST-T wave traits identified 71 significant genotype--phenotype associations in 28 genetic loci (2 MB). The *x*-axis represents the chromosomal position for each SNP, which was assigned the lowest *P*-value across the 12 traits; the *y*-axis represents the −log10 of the *P*-value for association. Twenty-seven loci were significant for ST-T-wave amplitudes. (**C**) Four genes overlapping four loci are directly involved in the cardiac action potential; SNPs near SCN5A were associated with ST-segment and T-top amplitudes whereas the loci containing potassium channel-coding genes *KCND3*, *KCNA7* and *KCNB1* were primarily associated with ST-segment amplitudes.

Next, we performed replication testing of the 95 genotype--phenotype associations (*P* \< 1 × 10^−6^) in 22 034 independent individuals derived from 7 independent cohorts ([Supplementary Material, Table S5](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)), identifying 71 genotype--phenotype associations in 28 independent loci to be replicated (*P* \< 0.01) and become genome-wide significantly associated (Fig. [1](#ddw058F1){ref-type="fig"}B, Table [1](#ddw058TB1){ref-type="table"} and [Supplementary Material, Table S4](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1) and [Fig. S1](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). Table 1.All sentinel SNP associations per ST-T wave phenotypeNo.RegionSNPTraitLD (*r*^2^) with Sentinel SNP^(†)^ in LocusEA (FRQ)/NEA*β* (SE)*P*~meta~*N*Gene11p36.33rs260505T.ant†A (0.49)/C0.05 (0.01)1.30E-1137775SKI^n^21p36.12rs2072944T.sep0.37T (0.55)/C0.05 (0.01)1.70E-1337821LUZP1^n^, KDM1A^n^, WNT4^e^21p36.12rs2298632ST.sep†T (0.47)/C−0.07 (0.01)4.40E-1837753TCEA3^ne^31p31.3rs2207792T.aVR--A (0.66)/G−0.06 (0.01)3.30E-1337799NFIA^nd^31p31.3rs2207792T.inf†A (0.66)/G0.07 (0.01)3.00E-2037810NFIA^nd^41p13.2rs12145374ST.ant--A (0.76)/C0.11 (0.01)5.90E-3337753KCND3^ng^, FAM212B^d^41p13.2rs12145374ST.sep--A (0.76)/C0.07 (0.01)1.20E-1437753KCND3^ng^, FAM212B^d^41p13.2rs12145374ST.aVR--A (0.76)/C−0.12 (0.01)1.40E-3137784KCND3^ng^, FAM212B^d^41p13.2rs12145374ST.lat†A (0.76)/C0.12 (0.01)8.20E-3437771KCND3^ng^, FAM212B^d^41p13.2rs12145374ST.inf--A (0.76)/C0.09 (0.01)6.00E-1837770KCND3^ng^, FAM212B^d^51q22rs10908505ST.aVR†A (0.66)/T−0.05 (0.01)1.70E-1137784MEF2D^ngd^61q23.3rs12567315T.ant0.42A (0.19)/G−0.06 (0.01)4.60E-1137775NOS1AP^n^61q23.3rs4657178T.inf†T (0.24)/C−0.06 (0.01)1.90E-1137810NOS1AP^n^71q24.2rs545833ST.ant†T (0.26)/C−0.06 (0.01)7.00E-1837753DPT^n^71q24.2rs511187ST.inf0.79A (0.72)/G0.06 (0.01)2.60E-1237770DPT^n^71q24.2rs511187ST.aVR0.79A (0.72)/G−0.07 (0.01)3.10E-1737784DPT^n^71q24.2rs511187ST.lat0.79A (0.72)/G0.07 (0.01)7.20E-1837771DPT^n^82p15rs7576036ST.sep†T (0.54)/C0.05 (0.01)2.80E-1037753XPO1^n^92q33.1rs1866666T.aVR†T (0.49)/C−0.05 (0.01)1.80E-1137799PLCL1^nced^, MARS2^e^, RFTN2^e^, MOB4^d^103p25.1rs4684185T.aVR†T (0.35)/C−0.05 (0.01)7.10E-1037799LSM3^n^, TMEM43^d^113p22.2rs7638909ST.sep0.02T (0.76)/G−0.06 (0.01)2.00E-1137753SCN5A^nd^, ACVR2B^d^113p22.2rs9851710\*T.inf0.03A (0.66)/C0.08 (0.01)9.30E-1937810SCN10A^n^, SCN5A^d^, ACVR2B^d^113p22.2rs7633988T.ant0.02A (0.71)/T0.06 (0.01)3.80E-1137775SCN10A^n^, SCN5A^d^, ACVR2B^d^113p22.2rs6783110T.lat0.94A (0.42)/G0.06 (0.01)3.70E-1230699SCN10A^nc^, SCN5A^d^, ACVR2B^d^113p22.2rs4076737T.aVR0.93T (0.57)/G0.07 (0.01)1.20E-2037799SCN10A^nc^, SCN5A^d^, ACVR2B^d^113p22.2rs4076737ST.inf0.93T(0.57)/G−0.07 (0.01)8.30E-2037770SCN10A^nc^, SCN5A^d^, ACVR2B^d^113p22.2rs6801957ST.aVR†T (0.43)/C−0.08 (0.01)1.10E-2537784SCN10A^nc^, SCN5A^d^, ACVR2B^d^113p22.2rs6801957ST.lat--T (0.43)/C0.06 (0.01)8.50E-1637771SCN10A^nc^, SCN5A^d^, ACVR2B^d^126p21.31rs7756236ST.ant†A (0.76)/G−0.06 (0.01)1.30E-1437753CDKN1A^ned^136q22.2rs210966ST.lat--C (0.28)/G0.07 (0.01)5.10E-1637771ROS1^n^, VGLL2^d^136q22.2rs210966ST.aVR†C (0.28)/G−0.07 (0.01)4.00E-1837784ROS1^n^, VGLL2^d^136q22.2rs172409ST.inf0.41A (0.54)/C−0.05 (0.01)6.40E-1130708ROS1^n^, VGLL2^d^146q22.31rs9388451ST.ant†T (0.52)/C−0.06 (0.01)2.00E-1837753HEY2^ned^146q22.31rs9388451T.ant--T (0.52)/C−0.05 (0.01)3.60E-1337775HEY2^ned^158p23.1rs1458942ST.aVR†A (0.60)/G0.06 (0.01)1.10E-1337784TNKS^nd^, SGK223^d^, XKR6^d^, PPP1R3B^d^168p23.1rs7011924ST.aVR†A (0.40)/G0.07 (0.01)1.30E-1937784DEFB136^n^, NEIL2^e^168p23.1rs7011924ST.inf--A (0.40)/G−0.07 (0.01)3.90E-1937770DEFB136^n^, NEIL2^e^1712p13.32rs7953399ST.sep0.95A (0.61)/G−0.04 (0.01)2.10E-0937753GALNT8^n^1712p13.32rs2286582ST.ant†T (0.40)/C0.06 (0.01)2.40E-1637753GALNT8^n^1812p12.1rs10842350T.lat--A (0.54)/G−0.09 (0.01)4.60E-3737759SOX5^ng^1812p12.1rs10842350T.aVR†A (0.54)/G0.09 (0.01)1.30E-3737799SOX5^ng^1912q24.21rs10850409T.sep†A (0.27)/G0.07 (0.01)4.30E-1734881TBX3^n^2013q22.1rs728926T.lat†T (0.38)/C−0.07 (0.01)2.00E-1837759KLF12^n^2013q22.1rs728926T.aVR--T (0.38)/C0.06 (0.01)1.50E-1637799KLF12^n^2115q26.3rs7174918ST.ant0.74T (0.29)/C−0.06 (0.01)6.90E-1637753IGF1R^nd^2115q26.3rs3803476T.sep--A (0.37)/G−0.05 (0.01)2.00E-1437821IGF1R^nd^2115q26.3rs3803476ST.sep†A (0.37)/G−0.07 (0.01)1.80E-2337753IGF1R^nd^2216p13.3rs7192150T.aVR†A (0.40)/G0.05 (0.01)4.30E-1337799LMF1^ne^, SOX8^gd^2316p13.13rs7191330T.aVR0.95T (0.46)/C−0.08 (0.01)3.10E-1630731LITAF^n^2316p13.13rs735951ST.ant--A (0.47)/G0.06 (0.01)9.50E-1737753LITAF^n^2316p13.13rs735951ST.aVR--A (0.47)/G−0.07 (0.01)1.70E-1837784LITAF^n^2316p13.13rs735951ST.lat†A (0.47)/G0.07 (0.01)1.20E-1837771LITAF^n^2416q21rs4784938ST.lat0.7A (0.74)/G0.08 (0.01)4.80E-2137771GINS3^n^2416q21rs4784939ST.ant--T (0.36)/C−0.09 (0.01)4.80E-4137753GINS3^n^2416q21rs4784939T.ant--T (0.36)/C−0.06 (0.01)1.00E-1737775GINS3^n^2416q21rs4784939T.sep--T (0.36)/C−0.08 (0.01)4.10E-2937821GINS3^n^2416q21rs4784939ST.sep†T (0.36)/C−0.11 (0.01)3.00E-5737753GINS3^n^2416q21rs8057901T.aVR0.93A (0.63)/G−0.06 (0.01)4.90E-1130731NDRG4^n^2416q21rs8057901ST.aVR0.93A (0.63)/G−0.08 (0.01)1.60E-2130713NDRG4^n^2416q21rs8057901ST.inf0.93A (0.63)/G0.07 (0.01)1.30E-1630708NDRG4^n^2416q21rs9940062T.inf0.94T (0.68)/G0.07 (0.01)1.20E-1030738NDRG4^n^2518q12.1rs8083566ST.lat--A (0.07)/C−0.09 (0.01)4.30E-1037771CDH2^nd^2518q12.1rs8083566ST.inf--A (0.07)/C−0.11 (0.02)1.70E-1237770CDH2^nd^2518q12.1rs8083566ST.aVR†A (0.07)/C0.12 (0.01)3.60E-1537784CDH2^nd^2619q13.33rs11673003ST.lat†A (0.90)/G−0.09 (0.01)5.10E-1437771KCNA7^nc^, NTF4^n^, GYS1^d^, HRC^d^2720q11.22rs6087666ST.inf†A (0.20)/G−0.07 (0.01)3.10E-1537770TRPC4AP^ne^, EDEM2^ce^, MYH7B^cd^, NCOA^d^2720q11.22rs6088738ST.aVR0.55A (0.21)/G0.06 (0.01)5.90E-1337784EDEM2^ne^, PROCR^e^, MYH7B^cd^, NCOA^d^2820q13.13rs11907908ST.ant0.83T (0.07)/C−0.12 (0.01)8.00E-1837753ZNFX1 (−AS1)^n^, STAU1^d^2820q13.13rs6019750ST.lat1C (0.93)/G0.13 (0.01)4.30E-2337771KCNB1^n^, STAU1^d^2820q13.13rs2202261ST.inf--A (0.93)/G0.12 (0.01)4.40E-1837770KCNB1^n^, STAU1^d^2820q13.13rs2202261ST.aVR†A (0.93)/G−0.14 (0.01)5.60E-2637784KCNB1^n^, STAU1^d^[^1]

The majority of loci that show multiple genotype--phenotype associations in the same locus consist of sentinel SNPs that are either the same SNP or in LD with each other, as indicated by the LD (*r*^2^) column in Table [1](#ddw058TB1){ref-type="table"}. Conditional analysis within the discovery set revealed a secondary signal \[rs9851710 conditioned on rs6801957: *β* (SE) per minor allele = 0.13 (0.0204), *P* = 2.38 × 10^−10^\] in the SCN5A/SCN10A locus to be associated with ST aVR amplitudes. This SNP has also been identified to be associated with other ST-T phenotypes (see Table [1](#ddw058TB1){ref-type="table"}), suggesting that there are 29 independent signals within the 28 loci.

Some loci were predominantly associated with ST-segment amplitudes (locus 4, 5, 16, 26 and 28) while others were predominantly associated with T-wave amplitudes (locus 6, 18 and 29). The test statistics for every combination of genotype--phenotype association are summarized in [Supplementary Material, Table S6](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1).

Other electrocardiographic traits {#s2b}
---------------------------------

Previous genome-wide associations have studied other ECG indices ([@ddw058C1],[@ddw058C19]--[@ddw058C23]) such as QRS duration, PR interval, heart rate and QT interval. We intersected these previously identified loci with our ST-T-wave loci and found overlap (within 2 MB) in 13 loci. Lead SNPs from previous and current findings in 4 loci were in low LD (*r^2^* \< 0.02), suggesting that 19 of the current loci are novel associations with the ECG ([Supplementary Material, Table S7](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)).

Heritability estimates {#s2c}
----------------------

The 28 identified sentinel SNPs collectively explained between 1.6% (T-wave septal) and 5.1% (ST-segment aVR) of the observed phenotypic variance ([Supplementary Material, Table S8](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). Familial heritability estimates in the Erasmus Rucphen Family (ERF) study varied between *h*^2^ = 30% (T-wave inferior) and *h*^2^ = 42% (ST septal) suggesting additional genetic variants and other mechanisms that remain to be discovered ([Supplementary Material, Table S9](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). The variation in proportion of variance associated with covariates varied more widely; between *r^2^* = 0.09 (ST-segment inferior) and *r*^2^ = 0.36 (ST-segment septal).

Identification of candidate genes and pathway analyses {#s2d}
------------------------------------------------------

In total, we prioritized 54 candidate genes in the 28 genetic loci (Table [1](#ddw058TB1){ref-type="table"}) that could play a causal role in ST-T-wave amplitudes based on several criteria, as described in the 'Materials and Methods' section. Thirty-four genes were prioritized based on the proximity criteria, 5 genes contained one or more non-synonymous SNPs in high LD with a lead SNP ([Supplementary Material, Table S10](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)), 12 genes had a top-eQTL SNP in high LD with a lead SNP ([Supplementary Material, Table S11](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)), 65 genes were selected by the data-driven expression prioritized integration for complex trait (DEPICT) analysis of which 25 were within genome-wide significant loci (at false discovery rate ≤ 5%; [Supplementary Material, Table S12](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)) and 3 genes are based on literature mining using GRAIL ([Supplementary Material, Table S13](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). The top five keywords retrieved from GRAIL were 'muscle', 'channel', 'transcription', 'heart' and 'channels'.

The DEPICT method ([@ddw058C24]) was applied to subsequently offer insight into the biological pathways underlying changes in ST-T-wave amplitudes of the ECG. DEPICT identified 56 reconstituted gene sets, which grouped into 9 distinct clusters. The cluster containing the most significantly enriched reconstituted gene set ('VCL protein complex', a protein--protein interaction network centered on the Vinculin gene product, *P* = 6.00 × 10^−6^) represented various protein complexes likely related to Fascia Adherens, while the second most significant gene cluster 'Abnormal Cardiovascular System Physiology' contains reconstituted gene set known to be important for cardiac repolarization (Fig. [2](#ddw058F2){ref-type="fig"} and [Supplementary Material, Table S14](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). Figure 2.(**A**) DEPICT identified 56 significantly enriched gene-sets relevant for ST-T-wave amplitudes. (**B**) SNPs were significantly more enriched in DHSs of fetal heart tissue (*n* = 12) compared with other tissue and cells (*n* = 337), across the full range of *P*-values of the discovery meta-analyses (genome wide), suggesting that functionality of regulatory DNA elements may underlie some of the associations. (**C** and **D**) Next, we performed a meta-analysis of the 28 identified ST-T wave loci using 1000 Genomes imputed data, for this 1000G variants needed to be in LD *r*^2^ \> 0.1 with the HapMap sentinel SNP. Subsequent prioritization of potential causal annotations in these loci also suggested that regions of DHS in fetal heart are possibly underlying the associations as well as cardiac transcription factors, conserved regions (exonic), active and weak enhancers. While regions that are transcribed, tightly packed (heterochromatin) or function as promoters in the ventricles may be less important for the biological mechanisms of genetic variants that are associated with ST-T-wave amplitudes. Subtle difference are present between the ventricles and fetal heart which could suggest that promoters that overlap potential causal ST-T wave SNPs may be active in the fetal heart but repressed in the ventricles. Percentages *between parentheses* indicate the amount of SNPs in the 28 loci overlapping with the annotation. Conservation (GERP and 29 mammals), DHS of fetal heart, enhancers of the left ventricle and Tbx3 bound regions were used to prioritize potential causal SNPs in the 28 loci.

Role of regulatory DNA and 1000 genomes imputation {#s2e}
--------------------------------------------------

ST-T-wave associated SNPs were 3-fold enriched in Dnase1 Hypersensitivity sites (DHSs) from human fetal heart (Fig. [2](#ddw058F2){ref-type="fig"}), which was significantly higher compared with 337 other cell types and tissues (*P* = 0.0004, *Z*-score statistics) in line with earlier observations ([@ddw058C25],[@ddw058C26]). We then performed fine mapping of all 71 genome-wide significant genotype--phenotype associations (Table [1](#ddw058TB1){ref-type="table"}) in prevention of renal and vascular end-stage disease (Prevend) and Lifelines imputed with 1000 genomes (1000G), covering more of the known common variants in humans. We observed that 64 (of 71) associations were assigned to a different lead SNP, that 63 of these associations were more significant in the 1000G imputed data and effect estimates were higher for 58 of these associations ([Supplementary Material, Table S16](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). To facilitate future functional experiments toward the identification of causal variants and their underlying biological mechanisms, we prioritized potential causal SNPs using the probabilistic framework of Probabilistic Annotation INTegratOR (PAINTOR) ([@ddw058C27]). PAINTOR determined the significance of each annotation (Fig. [2](#ddw058F2){ref-type="fig"}) and used the five most significant annotations (conservation scores, DHS of fetal heart, enhancers of the left ventricle and *Tbx3* bound regions) to prioritize potential causal SNPs in the 28 loci ([@ddw058C27]). This yielded 315 SNPs in the 99% confidence set and 96 SNPs in the 95% confidence set ([Supplementary Material, Table S17](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)).

Discussion {#s3}
==========

Amplitudes of the ST segment and T wave are important traits that are associated with abnormal heart rhythm, conduction disturbances and ventricular arrhythmias. In this study, we performed the first GWAS of ST-T-wave amplitudes of the ECG in up to 37 977 individuals. Traits were defined according to the combination of ECG leads presumed to have anatomical meaning or used in the clinic for diagnosing Brugada syndrome and early repolarization ([@ddw058C16]--[@ddw058C18]). ST-T-wave traits were moderately heritable (*h*^2^ = 30--42%) while the proportion of variance associated with covariates (gender, body mass index and age) varied considerably (9--36%) strongly supporting the genetic background of these traits. We identified 28 genome-wide significant loci for ST-T-wave amplitudes and a set of 54 candidate genes.

A recent GWAS on Brugada syndrome revealed the association of two loci that are shared by our ST-T-wave loci ([@ddw058C28]). One of these signals in the SCN5A/SCN10A locus is in complete LD with our sentinel SNP (rs10428132, *r^2^* = 0.96 with rs6801957) and rs9388451 near *HEY2*, is a ST-T-wave sentinel SNP; suggesting that Brugada syndrome susceptibility loci share a common genetic background with ST-T-wave traits. One of the strongest associated GWAS signals for all amplitudes of the ST segment was in the *KCND3* gene (locus 4). *KCND3* encodes the Kv4.3 α-subunit that conducts the cardiac fast transient outward K+ current (*I*~To,f~). This current is prominent in Phase 1 of the action potential and contributes to the 'notch' of the cardiomyocyte\'s action potential ([@ddw058C2]). Mutations in *KCND3* have been implicated with increased risk of sudden cardiac death ([@ddw058C29],[@ddw058C30]), as well as mutations in *SCN5A* ([@ddw058C2]) and *SCN10A* ([@ddw058C31]). We specifically identified loci containing potassium channels *KCND3* (locus 4), *KCNB1* (locus 28) and *KCNA7* (locus 26) to be predominantly associated with amplitudes of the ST segment and not with the T wave, suggesting that these potassium channels are activated during the ST segment of the repolarization phase and may have clinical relevance ([@ddw058C16],[@ddw058C32],[@ddw058C33]). Future studies are required to examine the potential role of the other ST-T-wave SNPs for increased arrhythmogenic risk and sudden death through an altered cardiac repolarization.

In addition to *HEY2*, a transcriptional regulator of cardiac electrical function in the right ventricular outflow tract ([@ddw058C28]), we identified six loci containing genes with strong evidence of being directly involved in cardiac tissue development via transcriptional regulatory pathways. Locus 5 contains a myocyte enhancer factor-2 (*MEF2D*) important for cardiac muscle morphogenesis and heart looping ([@ddw058C34],[@ddw058C35]). Loci 18 and 22 contain two transcription factors from the SOX family, *SOX5* and *SOX8. SOX5* is important for a functioning heart and involved in correct Wnt signaling ([@ddw058C36]). This locus has previously been associated with the PR interval and resting heart rate, but the identified variant in the current study is in low LD (*r*^2^ = 0.01), suggesting multiple molecular-genetic mechanisms at this locus to influence heart function. Transcripts of *SOX8* are concentrated in the subendothelial mesenchym of the whole outflow tract ([@ddw058C37]) in which N-Cadherin ([@ddw058C38]) (encoded by *CDH2*, locus 25), the transcription factor Tbx3 ([@ddw058C39]) (*TBX3*, locus 19) and WNT4 ([@ddw058C40]) (specific for the endocardial endothelial cushion development, part of the Wnt pathway) in locus 2 also play essential developmental roles, among other cardiac cell lineages. Other compelling cardiac genes are: *SKI*, for which mutations (1p36 deletion- and Sprintzen--Goldberg syndrome) are characterized by heart defects, brain abnormalities and muscle tone (hypotonia) in infancy ([@ddw058C41]); *TMEM43* (locus 10) in which mutations cause arrhythmogenic right ventricular cardiomyopathy and Emery--Dreifuss muscular dystrophy; the sarcomeric gene *MYH7B* and miR499 (locus 27), which regulates a multitude of cardiac mRNA and microRNAs and promotes ventricular specification; and *GALNT1*, a glycosyltransferases that is required for normal heart valve development and cardiac function by regulating the extracellular matrix and altering conserved signaling pathways that regulate cell proliferation during heart development ([@ddw058C42]). We also identified a number of less well-characterized genes, which should be explored in further research.

Five of the 28 ST-T-wave sentinel SNPs were in LD with SNPs associated with QT duration ([@ddw058C1]), suggesting that ST-T-wave amplitudes provides additional information on cardiac repolarization. The known functions of the candidate genes and our pathway analyses suggest that the ST-T-wave amplitudes are influenced and regulated by a wide variety of molecular mechanisms, including ion-channels, structural proteins and cardiac transcription factors. However, the finding that protein complexes related to Fascia Adherens are most enriched in our pathway analyses hints that some of the biology underlying ST-T waves is less well captured in well-established pathways and better represented by data-driven (and not manually curated) pathways.

Ventricular repolarization is a complex process. To capture this process, we chose to apply a selection of composite ECG parameters with the aim of gaining more insight into the biological processes underlying the ST-T wave. These surface ECG parameters are not specific enough to identify the exact anatomical region of the heart; e.g. the septal leads (V~1~ and V~2~) may also include aspects of the right ventricular wall activity. However, there are no data available of more precise measurements such as could be derived from more sophisticated surface ECG equipment or intra-cardiac ECG measurements.

In summary, we present a large number of genome-wide significant loci robustly associated with cardiac repolarization parameters, some with compelling biological basis for their association and a number of loci not previously implicated in cardiac function. The identified loci and selected genes have the potential to aid future studies that are focused on risk stratification or on molecular mechanisms underlying cardiac repolarization and diseases of cardiac repolarization; to facilitate these studies, we have made our results (including the genome-wide association) publicly available.

Materials and Methods {#s4}
=====================

Study populations {#s4a}
-----------------

The discovery phase included participants of the Prevend study and the Lifelines study cohort. Both are community-based cohort studies from the northern part of the Netherlands. The replication phase included participants of the Atherosclerosis Risk in Communities study (ARIC), Cardiovascular Health Study (CHS), Young Finns Study (YFS), ERF study, Rotterdam study I, II and III (RS I, II and III). Detailed descriptions of each cohort are given in the supplementary material. Characteristics of participants are summarized in [Supplementary Material, Tables S1 and S5](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1). Detailed Information on genotyping methods, quality control of SNPs, imputation and statistical analysis for each cohort is summarized in [Supplementary Material, Table S18](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1).

Phenotype modeling {#s4b}
------------------

Summing correlated variables when expecting that genetic variants are associated to multiple of these variables will increase the power for detection; with genetic variant (Snp), and traits (Ampitude~i~), consider the correlation: *Corr(Snp, Ampitude~1~* + *Ampitude~2~)* = *Corr(Snp, Ampitude~1~)* + *Corr(Snp, Ampitude~2~)* + *2* × *Corr(Ampitude~1~, Ampitude~2~)* \> *Corr(Snp, Ampitude~1~)* + *Corr(Snp, Ampitude~2~)*, hence if *Corr(Ampitude~1~, Ampitude~2~)* \> *0*, the traits Ampitude~i~ measure the same latent variable (*L*). Therefore, phenotypes for the ST-segment amplitudes 80 ms after J-point and T-wave amplitudes were defined by taking the sum of the lateral (I, aVL, V~5~ and V~6~), inferior (II, III and aVF), septal (V~1~ and V~2~), anterior (V~3~ and V~4~) leads and lead aVR. Individuals were excluded for bundle branch block or QRS duration \> 120 ms, atrial fibrillation, flutter, history of myocardial infarction or electronic pacemaker rhythm and when available, heart failure and ECG altering medication. Also participants with extreme measurements (more than ±4SD from mean) were excluded on a per phenotype basis.

Statistical analyses {#s4c}
--------------------

To control for multiple testing of the 10 phenotypes while accounting for the correlation between them, we performed an eigenvalue decomposition of the correlation matrix ([Supplementary Material, Table S2](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)) of the phenotypes. The variance of the eigenvalues \[Var (*λ*~obs~) = 2.36\] was used to estimate the effective number of independent phenotypes tested ([@ddw058C43]). Our findings indicate that studying 10-related ST-T-wave traits is equivalent to analysis of 8 independent phenotypes. We, therefore, adopt *α*~a~ = 5 × 10^−8^/8 = 6.25 × 10^−9^ as threshold for declaring genome-wide significance in order to correct for the effective number of independent phenotypes studied.

Residuals of ST-T-wave amplitudes were calculated using general linear regression models to adjust for age, gender and body mass index and standardized to a mean of zero and a standard deviation of one. GWAS analyses in Prevend and Lifelines of 2 316 136 genotyped or imputed SNPs ([Supplementary Material, Table S18](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)) were performed on the standardized residuals using an additive genetic model in PLINK (v.1.07). Phenotypes were normally distributed ([Supplementary Material, Fig. S2](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). Test statistics from each cohort were then corrected for their respective genomic control inflation factor to adjust for residual population sub-structure and meta-analyzed using the inverse-variance method. SNPs with minor allele frequency \< 1% (weighted average across cohorts) were removed. Variants were considered to be independent if the pair-wise LD (*r^2^*) was \<0.1 and if they were separated by at least 1 MB; this was defined a 'locus'. We selected one sentinel SNP (the most-significantly associated SNP in a locus) for each genotype--phenotype combination.

For conditional analyses, we repeated the primary association analysis for each trait while conditioning on the trait-specific genome-wide significant sentinel SNPs by adding the SNP genotypes as covariates. Association results for each study were again combined by inverse variance weighting.

Replication of the significant genotype--phenotype associations (*P* \< 6.25 × 10^−9^) and associations that did not exceed this threshold, but were suggestive (6.25 × 10^−9^ \< *P* \<1 × 10^−6^), was performed in the RS I, II and III, ERF, ARIC, CHS and YFS and combined using fixed-effects meta-analysis by inverse variance weighting ([Supplementary Material, Table S18](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). The pre-specified statistical significance threshold for heterogeneity by Cochran\'s *Q* (*P*~het~) was *P*~het~ \< 0.0007 to account for multiple testing. Inverse variance weighting was used to determine meta-*P*-values for combined discovery and replication data. An association was considered replicated if the direction of effect was concordant with discovery, replication *P* \< 0.01 and meta-*P* \< 6.25 × 10^−9^.

Heritability estimates were calculated in the ERF study using the 'tdist' function in the SOLAR software, including gender, age and body mass index as covariates.

Data-driven expression prioritized integration for complex traits {#s4d}
-----------------------------------------------------------------

DEPICT systematically identifies the most likely causal gene at a given associated locus, tests gene sets for enrichment in associated SNPs, and identifies tissues and cell types in which genes from associated loci are highly expressed \[see Pers *et al*. ([@ddw058C24]) for a detailed description\]. For this work, we ran DEPICT on 140 independently associated loci (association *P* \< 10^−5^; PLINK parameters, '\--clump-p1 1e-5 \--clump-kb 500 \--clump-r2 0.05') resulting in 103 independent, autosomal DEPICT loci containing 363 genes (loci overlapping with the major histocompatibility complex region are by default excluded in DEPICT). We have extended the locus definition used in DEPICT (LD *r*^2^ \> 0.5) with 100 kb at either side of the loci, because several genes that may be important for cardiac repolarization were outside the default DEPICT locus boundaries (e.g. *SCN5A*, *TMEM43* and *VGLL2*). The gene set enrichment results for this slightly extended locus definition were similar to the results based on the default locus definition used in DEPICT ([Supplementary Material, Table S19](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)).

Identification of candidate genes {#s4e}
---------------------------------

We prioritized candidate genes based on *nearby genes*: we considered the nearest gene and any other gene located within 10 kb of the sentinel SNP. *Coding variants*: for identification of coding variants and LD calculations, we used the 1000G Project data set (March 2012 release) in the European populations. We considered genes that harbor non-synonymous SNPs in LD with the ST-T-wave SNPs at *r^2^* \> 0.8. GRAIL analyses: we carried out a literature analysis by employing the GRAIL text-mining algorithm, a statistical tool that identifies subsets of genes with known functional interrelationships based on PubMed abstracts. We carried out the analysis using the 2006 data set to avoid confounding by subsequent GWAS discovery. The *DEPICT* method (see above), and *expression QTL (eQTL) analyses* in *cis*, we search for eQTLs (sentinel SNPs or SNPs in LD, *r*^2^ \> 0.8, HapMap r27) in an eQTL data set that was compiled from the summary statistics of various studies and tissues (see [Supplementary Material, Table S11](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)). We only considered eQTLs that were in LD (*r*^2^ \> 0.8, HapMap r27) with the sentinel SNP and reached a *P*-value cut-off of at least *P* \< 0.05/(28 loci × 17 eQTL studies).

Imputation using 1000G {#s4f}
----------------------

Genome positions from the Prevend and Lifelines genotypes were converted from hg18 to hg19 using the UCSC LiftOver tool. Genome-wide genotype imputation was performed with SHAPEIT (v2) and IMPUTE2 (v2.3.0) using the complete 1000 Genomes v3, March 2012 haplotypes Phase I integrated variant set release as reference panel.

Functional information {#s4g}
----------------------

We overlapped SNPs with data from the ENCODE project ([@ddw058C44]) and Roadmap Epigenomics Program ([@ddw058C45]), conservation across mammals, various cardiac transcription factor measured by ChIP-Seq and contiguous annotations of the human fetal heart, left ventricle and right ventricle as determined by ChromHMM ([@ddw058C46]) ([Supplementary Material](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)).

Prioritization of potentially causal variants and enrichment of DNA elements {#s4h}
----------------------------------------------------------------------------

For the prioritization of genetic variants for the future functional follow-up and insight of the underlying DNA elements that might be relevant for causal ST-T-wave amplitude variants, we employed the PAINTOR framework ([@ddw058C27]). In short, this method allows us to prioritize genetic variants in each of the 28 significant associated loci by an integrating strength of association and annotations of functional DNA elements to estimate the probability for each variant to be causal, but also investigate which annotations are potentially causal.

Supplementary Material {#s5}
======================

[Supplementary Material is available at *HMG* online.](http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw058/-/DC1)
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[^1]: There are 71 genome-wide significant genotype--phenotype associations clustered in 28 genetic loci (based on a 2 MB locus definition, see the 'Materials and Methods' section). Gene superscripts indicate the method of identification: n, nearest gene or nearby gene (within 10 kb of the SNP); g, Grail' d, Depict; e, eQTL; c, coding SNP (non-synonymous). rs9851710 denoted by an asterisk (\*) indicates that this SNP is an independent, secondary, association for ST.aVR (rs9851710 conditioned on rs6801957: *β* (SE) per minor allele = 0.13 (0.0204), *P* = 2.38 × 10^−10^).
